Description

Edited by experts from one of the world’s largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials.

Topics include:

  • Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors)
  • Ras inhibitors
  • Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors)
  • Lenalidomide analogs
  • New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine
  • Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib)
  • New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40)
  • Thrombopoietic agents

Leukemias: Principles and Practice of Therapy

  • Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease
  • Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area

Leukemias: Principles and Practice of Therapy

Product form

£162.34

Includes FREE delivery
Usually despatched within 12 days
Hardback by Stefan Faderl , Hagop Kantarjian

2 in stock

Short Description:

Edited by experts from one of the world’s largest leukemia centers, this book provides information on the biology of the... Read more

    Publisher: John Wiley and Sons Ltd
    Publication Date: 23/11/2010
    ISBN13: 9781405182355, 978-1405182355
    ISBN10: 1405182350

    Number of Pages: 456

    Non Fiction , Education

    Description

    Edited by experts from one of the world’s largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials.

    Topics include:

    • Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors)
    • Ras inhibitors
    • Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors)
    • Lenalidomide analogs
    • New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine
    • Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib)
    • New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40)
    • Thrombopoietic agents

    Leukemias: Principles and Practice of Therapy

    • Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease
    • Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area

    Customer Reviews

    Be the first to write a review
    0%
    (0)
    0%
    (0)
    0%
    (0)
    0%
    (0)
    0%
    (0)

    Recently viewed products

    © 2024 Book Curl,

      • American Express
      • Apple Pay
      • Diners Club
      • Discover
      • Google Pay
      • Maestro
      • Mastercard
      • PayPal
      • Shop Pay
      • Union Pay
      • Visa

      Login

      Forgot your password?

      Don't have an account yet?
      Create account